Search - tctmd.com

Displaying 241 - 260 of 420

Presentation TCT 2018

Case #1: A Case of TAVR ViV Requiring an Advanced Approach

Presenter: Massimo Napodano, Bernard Prendergast, Mohamed Abdel-Wahab, Robert J. Applegate, Vinayak Bapat, Alaide Chieffo, Jan Kovac, Juan A. Terré

September 22, 2018

Presentation TCT 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Michael J. Mack, Bernard Prendergast, Adnan K. Chhatriwalla

September 22, 2018

Presentation TCT 2018

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Michael J. Mack, Bernard Prendergast, John G. Webb

September 22, 2018

Presentation TCT 2018

TCT-5: Long-term Preclinical in Vivo Results With a Restorative Aortic Valve

Presenter: Steven R. Bailey, Patrick W. Serruys, Christian M. Spaulding

September 22, 2018

Presentation TCT 2018

TCT-56: High-Resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury

Presenter: John A. Ambrose, Farouc A Jaffer, Zhonglie Piao

September 21, 2018

Presentation TCT 2018

TCT-17: Tricuspid Valve Regurgitation Reduction Following Concomitant Subvalvular and Annulus-Level Treatment Ex-Vivo Study

Presenter: Eric Eeckhout, Glenn Van Langenhove, Michal Jaworek

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

ICE Guidance of LAA Closure

Presenter: Rebecca T. Hahn, Thomas Smith, Vivek Y. Reddy

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Presenter: William A. Gray, Gregg W. Stone, Vivek Y. Reddy

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Surgical Approaches and Emerging Data for LAA Closure: Are the Results Robust?

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Subhasis Chatterjee

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Shephal Doshi

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Ashish Pershad

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Gregg W. Stone

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Rajan Gadhia

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Presenter: A. Pieter Kappetein, Dee Dee Wang, Costantino Costantini, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Mitral Valve-in Valve and Ring I: Insights From the VIVID Registry

Presenter: Mayra Guerrero, Lars Sondergaard, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pick Your Poison: Complex Aortic Valve and Mitral Valve Disease

Presenter: Patrick M. McCarthy, David Meerkin, Vivian Ng, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Advertisement

Case #1: A Case of TAVR ViV Requiring an Advanced Approach

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Clinical Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

TCT-5: Long-term Preclinical in Vivo Results With a Restorative Aortic Valve

TCT-56: High-Resolution Intravascular OCT-NIRF Molecular Imaging for In Vivo Assessment of Inflammation in Atherosclerosis and Vascular Injury

TCT-17: Tricuspid Valve Regurgitation Reduction Following Concomitant Subvalvular and Annulus-Level Treatment Ex-Vivo Study

ICE Guidance of LAA Closure

Indications and Uncertainties for Atrial Fibrillation Treatment: Risk Scores, Single AF Episode, Post-CABG AF, Valvular vs. Nonvalvular, and More

Surgical Approaches and Emerging Data for LAA Closure: Are the Results Robust?

Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations

Atrial Fibrillation + PCI: The Myths and Realities of Triple Therapy

Pharmacologic Agents to Prevent Stroke in Nonvalvular Atrial Fibrillation and PFO: Evidence and Real-world Practices

Cardioembolic Stroke: Scope, Etiologies, Guidelines, and Uncertainties

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Mitral Valve-in Valve and Ring I: Insights From the VIVID Registry

Pick Your Poison: Complex Aortic Valve and Mitral Valve Disease

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content